Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
Thorax doi:10.1136/thoraxjnl-2014-206719 Respiratory research Original article Nicola A Hanania1, Michael Noonan2, Jonathan Corren3, Phillip Korenblat4, Yanan Zheng5, Saloumeh K Fischer5, Melissa Cheu5, Wendy S Putnam5, Elaine Murray5, Heleen Scheerens5, Cecile TJ Holweg5, Romeo Maciuca5, Sarah Gray5, Ramona Doyle5, Dana McClintock5, Julie Olsson5, John G Matthews5, Karl Yen5 +Author Affiliations 1Section of Pulmonary and Critical Care Medicine, Baylor […]
Bronchial Thermoplasty: Non-drug treatment option for severe asthma
First interventional therapy for adults with severe uncontrolled asthma. Bronchial Thermoplasty, a clinically proven, long lasting therapy that transforms the lives of adults with uncontrolled severe asthma for at least 5 years may be an alternative treatment option. (Wechsler et al, for the AIR2 Trial Study Group. Bronchial Thermoplasty: Long-term safety and effectiveness in patients […]
Reduction of Airway Smooth Muscle Mass after Bronchial Thermoplasty: Are We There Yet?
Peter I. Bonta M.D., Ph.D. 1, Julia d’Hooghe M.D. 1, Peter J. Sterk Ph.D. 1, Elisabeth H. Bel M.D., Ph.D. 1, and Jouke T. Annema M.D., Ph.D. 1 +Author Affiliations Read More: http://www.atsjournals.org/doi/abs/10.1164/rccm.201502-0334LE#.VV3AtVl_Oko
Stepping down from inhaled corticosteroids with leukotriene inhibitors in asthma: A systematic review and meta-analysis
Allergy Asthma Proc. 2015 May-Jun; 36(3): 200–205. doi: 10.2500/aap.2015.36.3839 PMCID: PMC4405599 Matthew A. Rank, M.D.,1 Michael R. Gionfriddo, Pharm.D.,2 Thanai Pongdee, M.D.,3 Gerald W. Volcheck, M.D.,4James T. Li, M.D., Ph.D.,4 Christina R. Hagan,5 Patricia J. Erwin, M.L.S.,6 and John B. Hagan, M.D.4 Author information ► Copyright and License information ► Abstract Background: The risks of using leukotriene receptor antagonists (LTRA) as part of a strategy […]
How to use inhalers
70% of people use inhalers incorrectly! Evaluate your inhaler technique… Free Training (1 Minute) 1.Select Language: English Español Português Français Italiano Polski 中国的العربية Việt हिंदी русский kreyòl ayisyen 2. Select an Inhaler: MDI with Spacer MDI Diskus Handihaler Twisthaler Autohaler Aerolizer Flexhaler Neohaler Respimat Pressair […]
Population Health for Children With Asthma: Time to Let Some Fresh Air In
Louis Vernacchio, MD, MSc Commentary Free I must confess that as a primary care pediatrician, treating asthma often feels stale: same old medications, same old conversations about the importance of daily controllers, same old preventable emergency department visits and hospitalizations. But in this issue of Pediatrics, Beck et al1 present a novel ecologic analysis that […]
Asthma Research and Practice
Editors-in-Chief Juan C. Celedón University of Pittsburgh, United States – Giovanni Passalacqua University of Genoa, Italy Founding Editor Carlos E Baena-Cagnani Catholic University of Cordoba, Argentina About Asthma Research and Practice Aims and scope | Open access | Article-processing charges | Indexing services |Publication and peer review process | Editorial policies |Citing articles in Asthma Research and Practice |Why publish your article in Asthma Research and Practice? This page includes information about […]
Bronchial Thermoplasty: A non pharmacological approach
The Clinical Respiratory Journal Accepted Article (Accepted, unedited articles published online and citable. The final edited and typeset version of record will appear in future.) Saurabh. Kumar. Singh1,* and Kamlesh Kumar Tiwari2 DOI: 10.1111/crj.12315 Abstract Asthma is a chronic inflammatory disorder of the airway characterized by the episodic symptoms of breathlessness, wheezes and cough. Even with the […]
Anti-inflammatory effects of PGE2 in the lung: role of the EP4 receptor subtype
Thorax doi:10.1136/thoraxjnl-2014-206592 Respiratory research Original article Mark A Birrell1,2, Sarah A Maher1, Bilel Dekkak1, Victoria Jones1, Sissie Wong1, Peter Brook1, Maria G Belvisi1,2 Abstract Background Asthma and chronic obstructive pulmonary disease (COPD) are chronic inflammatory diseases of the airway. Current treatment options (long acting β-adrenoceptor agonists and glucocorticosteroids) are not optimal as they are only effective in […]
Join our more than 1,000 followers on Twitter!
Join our more than 1,000 followers on Twitter! Twitter HomeNotificationsMessages Search querySearch Twitter Tweeter FOLLOWERS1,012 https://twitter.com/Interasma